bbHEP 01
Alternative Names: bbHEP-01Latest Information Update: 22 Dec 2023
At a glance
- Originator bit.bio
- Class Cell therapies; Induced pluripotent stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Liver failure
Highest Development Phases
- Preclinical Liver failure